Stable Isotope Labeled Biomolecules Market, By Type (D Labeled Biomolecules, 15N Labeled Biomolecules, 13C Labeled Biomolecules, and Others), By Application (Scientific Research, Medical, Industrial, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Stable Isotope Labeled Biomolecules Market accounted for US$ 168.2 Billion in 2024 and is estimated to be US$ 874.2 Billion by 2034 and is anticipated to register a CAGR of 19.8%.

Stable isotopes are non- radioactive isotopes having same number of protons but different neutrons in nucleus. Stable isotopes labelled compounds are synthetic molecules incorporating one or more stable isotopes into their chemical structure. These are used to investigate metabolic pathways, protein-protein interactions and in development of new drugs.

                       For More Report Details, Download Free Sample PDF

Regional Insights:

On region the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• North America market is estimated to witness a significantly high revenue share over the forecast period due to rising investment and funding, also growth of biopharmaceutical industry and larger nuclear industry.
• Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to rise in research activities and increasing health awareness.

Dividing this target market into segments:

Stable isotope labeled biomolecules market is segmented based on Type, Application and Region.

Type Insight

On the basis of Type, the target market is segmented into D Labeled Biomolecules, 15N Labeled Biomolecules, 13C Labeled Biomolecules, and Others

Application Insight

On the basis of Application, the target market is segmented into Scientific Research, Medical, Industrial, and Others

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034.

The key players operating the in the global stable isotope labeled biomolecules market includes, Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife, WITEGA Laboratorien, Omicron Biochemicals, Icon Isotopes, and Medical Isotopes.

Recent Development:

The New Launched Product News,

• In September 2022, Cambridge Isotope Laboratories, Inc. (CIL)  partnered with ISOtopic Solutions to release the new stable isotope-labeled and unlabeled Crude Lipid Yeast Extracts. These are designed to render hundreds of fatty acids and lipids for use in MS lipidomics research and development.
• In October 2021, Cambridge Isotope Laboratories, Inc. (CIL) announced the release of its new stable isotope-labeled and unlabeled TCA cycle mixes to aid in the analysis of TCA-associated compounds in metabolic studies. The TCA (tricarboxylic acid) cycle, also known as the Krebs or citric acid cycle, plays an essential role in central carbon and energy metabolism. The study of its intermediates, and its ancillary compounds, has proven pivotal in not only understanding their impact on metabolism but also in profiling their function in oncogenesis, inflammation, and other pathologies.